Open original FDA record ↗Recall record
- FDA identifier
- Z-2099-2016
- Company in FDA record
- Dako North America Inc.
- FDA record creation date
- Jun 29, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
An incorrect HER2 probe concentration was used when producing the probe component (Vial 3) in this kit lot. This has resulted in the HER2 probe concentration being too low.
Source facts
- Action
- Dako sent a recall notification dated June 10, 2016 to all customers. The letter identified the affected product, problem, the investigation findings, the affected results, and the actions to be taken. Customers are instructed to complete and return the enclosed device recall form to Dako QA Vigilance by Dako.dkvigilance@agilent.com. Customers with questions regarding the notification, are instructed to contact their sales representative.
- Initiated
- 2016-06-10
- Root cause
- Process control
- Terminated
- 2016-09-02
- Distribution
- Worldwide Distribution - US Nationwide in the states of: PA, CA, AL, NC and countries of Austria, Bosnia and Herzegovina, Belgium, Bulgaria, Brazil, Canada, Switzerland, Germany, Spain, France, Greece, Italy, Macedonia, Qatar, Romania, Serbia, Sweden, and Turkey.
- Recall number
- Z-2099-2016
- Recall status
- Terminated
- CDRH record ID
- 147442
- FDA record created
- 2016-06-29
- Recall event number
- 74408